Publication Name	World Journal of Hepatology
Manuscript ID	101165
Country	Iraq

Received	2024-09-10 06:04
Peer-Review Started	2024-09-19 01:11
To Make the First Decision
Return for Revision	2024-12-05 10:17
Revised	2024-12-09 07:32
Second Decision	2024-12-17 02:43
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-12-17 08:57
Articles in Press	2024-12-17 08:57
Publication Fee Transferred
Edit the Manuscript by Language Editor	2024-12-30 00:34
Typeset the Manuscript	2025-02-11 01:43
Publish the Manuscript Online	2025-02-20 08:39

ISSN	1948-5182 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medicine, Research & Experimental
Manuscript Type	Letter to the Editor
Article Title	Sarcopenia and metabolic dysfunction-associated steatotic liver disease: The role of exercise-related biomarkers
Manuscript Source	Invited Manuscript
All Author List	Marwan S Al-Nimer
ORCID	Author(s) ORCID Number Marwan S Al-Nimer http://orcid.org/0000-0002-5336-3353
Funding Agency and Grant Number
Corresponding Author	Marwan S Al-Nimer, MD, PhD, Department of Therapeutics and Clinical Pharmacology, College of Medicine, University of Diyala, University Street, Baqubah 32001, Iraq. marwanalnimer@yahoo.com
Key Words	Sarcopenia; Metabolic dysfunction associate-steatotic liver disease; Physical inactivity; Myokines; Irisin
Core Tip	Sarcopenia and metabolic dysfunction-associated steatotic liver disease (MDASLD) share similar physical inactivity, risk factors, and pathophysiology. In both conditions, physical inactivity is a remarkable clinical finding. Determination of irisin in the biological fluids serves as a good marker for physical activity as it elevates during muscle contraction. In sarcopenia, serum irisin declined, while in MDASLD it increased. Therefore, a transition of serum irisin from higher to lower levels in MDASLD could indicate the occurrence of sarcopenia.
Publish Date	2025-02-20 08:39
Citation	<p>Al-Nimer MS. Sarcopenia and metabolic dysfunction-associated steatotic liver disease: The role of exercise-related biomarkers. <i>World J Hepatol</i> 2025; 17(2): 101165</p>
URL	https://www.wjgnet.com/1948-5182/full/v17/i2/101165.htm
DOI	https://dx.doi.org/10.4254/wjh.v17.i2.101165

Full Article (PDF)	WJH-17-101165-with-cover.pdf
Manuscript File	101165_Auto_Edited_013247.docx
Answering Reviewers	101165-answering-reviewers.pdf
Audio Core Tip	101165-audio.m4a
Conflict-of-Interest Disclosure Form	101165-conflict-of-interest-statement.pdf
Copyright License Agreement	101165-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	101165-non-native-speakers.pdf
Peer-review Report	101165-peer-reviews.pdf
Scientific Misconduct Check	101165-scientific-misconduct-check.png
Scientific Editor Work List	101165-scientific-editor-work-list.pdf
CrossCheck Report	101165-crosscheck-report.pdf